Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122064703 | 12206470 | 3 | F | 20160628 | 20160324 | 20160707 | PER | US-PFIZER INC-2015316304 | PFIZER | 75.00 | YR | F | Y | 104.00000 | KG | 20160707 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122064703 | 12206470 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG ONCE A DAY CYCLIC (FOR 4 WEEKS FOLLOWED BY 2 WEEKS OFF) | 21938 | 25 | MG | CAPSULE, HARD | |||||||
| 122064703 | 12206470 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG, CYCLIC (1 TIME PER DAY; TAKE WITH OR WITHOUT FOOD FOR 4 WEEKS FOLLOWED BY 2 WEEKS OFF) | 21938 | 25 | MG | CAPSULE, HARD | |||||||
| 122064703 | 12206470 | 3 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 20 MG, 1X/DAY (ONE HALF TABLET OF 40 MG A DAY) | U | 0 | 20 | MG | TABLET | QD | ||||||
| 122064703 | 12206470 | 4 | SS | LOPRESSOR | METOPROLOL TARTRATE | 1 | 25 MG, 2X/DAYONE HALF OF 50 MG TWICE A DAY) | U | 0 | 25 | MG | BID | |||||||
| 122064703 | 12206470 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | CAPSULE | QD | |||||||
| 122064703 | 12206470 | 6 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, 1X/DAY | 0 | 81 | MG | QD | ||||||||
| 122064703 | 12206470 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122064703 | 12206470 | 1 | Renal cancer metastatic |
| 122064703 | 12206470 | 4 | Blood pressure abnormal |
| 122064703 | 12206470 | 5 | Abdominal discomfort |
| 122064703 | 12206470 | 6 | Anticoagulant therapy |
| 122064703 | 12206470 | 7 | Cardiac disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122064703 | 12206470 | Abdominal discomfort | |
| 122064703 | 12206470 | Blood glucose abnormal | |
| 122064703 | 12206470 | Condition aggravated | |
| 122064703 | 12206470 | Diarrhoea | |
| 122064703 | 12206470 | Influenza | |
| 122064703 | 12206470 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122064703 | 12206470 | 1 | 20150917 | 0 | ||
| 122064703 | 12206470 | 2 | 20160624 | 0 |